![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Novartis holds annual healthcare entrepreneur competition
Novartis has invited 60 selected students from leading international universities in 21 countries to its...
EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA)...
FDA approves new drug to treat HIV infection
The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat...
Novartis first company accredited with global CEO Cancer Gold Standard
Novartis is the first company to earn global CEO Cancer Gold Standard accreditation by the...
Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of...
Novartis has announced that results of a global Phase III study showed that Afinitor® (everolimus)...
Scientists discover potential new way to treat anxiety
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural...
GSK adds to its commitment to GAVI Alliance to help protect millions more children...
GlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing...
Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents
Small proteins called peptides that consist of 10 to 50 amino acids are being studied...
Studies suggest new key to ‘switching off’ hypertension
A team of University of California, San Diego researchers has designed new compounds that mimic...
New plan of attack in cancer fight
New research conducted by Harvard scientists is laying out a road map to one of...